HORA-PDE6B

N/A

Report date: 2024/05/08 15:18:22

Base Information

Drug NameHORA-PDE6B
Drug Alias NameCTx-PDE6bHORA-PDE6BAAV2/5-hPDE6B
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHorama Sa
China Registration ClassN/A

Develop Information

Active CompanieseyeDNA TherapeuticsThéa Open InnovationHorama Sa
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A